Browsing: drugs

Healthy Living

GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients | Harvard T.H. Chan School of Public Health

By

Boston, MA—Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle habits, according to a new study led by researchers at Harvard T.H. Chan School of Public Health and the Department of Veterans Affairs…

Healthy Living

New guidelines warn against obesity drugs for young children

By

Children under 10 should not be given obesity drugs or GLP-1 weight-loss injections such as Mounjaro and Wegovy, Dr Luz De Rigil, Director of Nutrition and Food Safety at WHO, said: ” for children under who does not recommend obesity medicines bariatric surgery or weight-management devices. this is a strong recommendation.>